Association between hemolytic state, ulcerative colitis and vitiligo

Authors

  • Teresa Isabel Simón Boada Hospital General Docente “Dr. Juan Bruno Zayas Alfonso”, Universidad de Ciencias Médicas, Santiago de Cuba
  • Lidia C. Suárez Beyries Hospital General Docente “Dr. Juan Bruno Zayas Alfonso”, Universidad de Ciencias Médicas, Santiago de Cuba
  • María A. Marishal Feliú Hospital General Docente “Dr. Juan Bruno Zayas Alfonso”, Universidad de Ciencias Médicas, Santiago de Cuba

Keywords:

autoimmune hemolytic state, ulcerative colitis, vitiligo, Coombs test, secondary health care.

Abstract

The case reports of 2 young adults of both sexes are described, assisted in the Internal Medicine Service of “Dr. Juan Bruno Zayas Alfonso” Teaching General Hospital in Santiago de Cuba with similar clinical patterns (marked weakness, easy fatigue, heart racing, increase of volume of lower limbs and bony pains, among others). The results of the physical and complementary exams confirmed that it was an association of ulcerative colitis, autoimmune hemolytic state and vitiligo. That is why it is necessary to carry out a deep study in each patient that presents any of these clinical disorders.

Downloads

Download data is not yet available.

Author Biography

Teresa Isabel Simón Boada, Hospital General Docente “Dr. Juan Bruno Zayas Alfonso”, Universidad de Ciencias Médicas, Santiago de Cuba

  1. Digestive Diseases and Sciences April 1979, Volume 24, Issue 4
  2. Williams WJ, Beutler E, Ersleu AJ, Rundles RW: Hematology, 2nd ed. New York McGraw Hill, 1977.
  3. Etzioni A. Immunodeficiency and autoimmunity. Autoimmun Rev 2003;2:364-9.
  4. Sleasman JW. The association between immunodeficiency and the development of autoimmune disease. Adv Dent Res 1996;10:57-61.
  5. Abbas AK. Inmunología celular y molecular. 6 ed. Madrid: Elsevier Saunders; 2008. p.492.

References

1. Kaufman S, Chalmer B, Heilman R, Beeken W. A prospective study of the course of Crohn's disease. Digest Dis Sci. 1979; 24(4): 269.

2. Etzioni A. Immune deficiency and autoimmunity. Rev Autoimmun. 2003;2(6):364-9.

3. Sleasman JW. The association between immunodeficiency and the development of autoimmune disease. Adv Dent Res. 1996;10(1):57-61.

4. Abbas AK. Inmunología celular y molecular. 6 ed. Madrid: Elsevier Saunders; 2008. p.492.

5. Muñiz E, Canals C, Nogués N. Anemia hemolítica autoinmune y transfusión En: Cortés A, León G, Muñoz M, Jaramillo S. Aplicaciones y práctica de la medicina transfusional. Santiago de Cali: GCIAMT;2012. p.135-752.

6. Murphy MF, Stanworth SJ. Haematological disease. En: Michael F, Murphy MF, Pamphilon DH. Transfusion medicine. 2th. Oxford: Wiley-Blackwell; 2005. p.119-31.

7. Valderrama Rojas M, Rodríguez Gorostiza FJ, Álvarez-Sala Walther LA, Torres Segovia FJ, Millán Núñez-Cortés J. Autoimmune hemolytic anemia: a rare complication of ulcerative colitis. An Med Interna. 2003;20(2):78-80.

8. Veloso T, Fraga J, Carvalho J, Dias L, Salgado M. Autoimmune hemolytic anemia in ulcerative colitis: a case report with review of the literature. J Clin Gastroenterol. 1991;13:445-7.

9. Chapel H, Lucas M, Lee M, Bjorkander J, Webster D, Grimbacher B, et al. Common variable inmunodediciency disorder: division into distinct phenotypes. Blood. 2008; 112(2):277-86.

10. Giannadaki E, Potamianos S, Roussomoustakaki M, Kyriakou D, Fragkiadakis N, Manousos ON. Autoimmune menolytic anemia and positive Coombs test associated with ulcertive colitis. Am J Gastroenterol. 1997;92:1872-4.

Downloads

Published

2016-11-07

How to Cite

1.
Simón Boada TI, Suárez Beyries LC, Marishal Feliú MA. Association between hemolytic state, ulcerative colitis and vitiligo. MEDISAN [Internet]. 2016 Nov. 7 [cited 2025 Jun. 4];20(11). Available from: https://medisan.sld.cu/index.php/san/article/view/699

Issue

Vol. 20 No. 11 (2016): MEDISAN

Section

Case Reports

License

All the articles can be downloaded or read for free. The journal does not charge any amount of money to the authors for the reception, edition or the publication of the articles, making the whole process completely free. Medisan has no embargo period and it is published under the license of Creative Commons, International Non Commercial Recognition 4.0, which authorizes the copy, reproduction and the total or partial distribution of the articles in any format or platform, with the conditions of citing the source of information and not to be used for profitable purposes.